Skip to content
The Nexus
DossierENTITY

biopharmaceutical companies

Coverage of biopharmaceutical companies in the Nexus archive.

Earliest in view: May 13 · 00:00 UTCMost recent: May 13 · 00:00 UTC
Co-mentioned in this coverage
Natureorganization1Governmentsorganization1
Recent coverage
  • HEALTHMay 13 · 00:00 UTCNATURE NEWS
    Economic reform can save antibiotic innovation

    The article discusses the need for economic reform to save antibiotic innovation, emphasizing the importance of governments creating incentives for biopharmaceutical companies. Governments must develop meaningful incentives for these companies to produce antimicrobial products. This is crucial for addressing the issue of antibiotic resistance.